This is a rocket ride you want no part of.
The Fool looks at 3 horrendous health-care stocks from the past week.
Affymax shares are taken to the woodshed due to a recall.
Let's look forward to this company's next earnings report.
Why the Affordable Care Act's individual mandate represents both an opportunity and a risk to health care investors.
One big trend Cardinal Health is taking advantage of with this major acquisition.
The health care company expands through acquisitions.
Finding companies that have all the right stuff can produce winners.
Affymax prepares to take on Amgen's 20-year hold on the dialysis market.
Earnings are coming out on Thursday the 17th. Here's what you need to be looking for.